Article

Scientists Explore the Role of Newly Discovered Protein in Immune System Response

The recent discovery of the protein, HVCN1, may provide some insight into the mechanics of autoimmune diseases, including rheumatoid arthritis, lupus and certain types of cancer.

The recent discovery of the protein, HVCN1, may provide some insight into the mechanics of autoimmune diseases, including rheumatoid arthritis, lupus and certain types of cancer.

Scientists at the University of Leicester published their findings in the journal of Nature Immunology.

The team was able to demonstrate HVCN1’s role in regulating antibody production through modulation of intracellular oxidation. When HVCN1 was not present, the immune system response was found to be blunted.

Researchers stated that the results were significant for the field of immunology and help to reveal how HCVN1 can be used as a target for therapies where activation of B cells need to be diminished.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.